🔘 Strengths/Limits of Lesion Specific vs Myocardial Ischemia
🔘 Comparing Dx Accuracy of Tests
🔘 Ischemia Testing in #INOCA
🔘 How to Select Best Noninvasive Test
☢ Issues with proposed #FFR threshold 0.8
☢ Exercise MPI correlates well with FFR but not at 0.8
☢ Benefit of FFR-guided revasc dominantly occurs w/ thresholds <0.8
☢ Quantification of lesion-specific #ischemia insufficient for patient mgmt
⚡️ FFR-CT is best of both worlds:
plaque burden + stenosis severity
☢ FFR guided revasc reduces revasc & QoL but doesn’t significantly reduce MI/death
☢ Not every CT can be analyzed for FFR-CT
☢ PACIFIC: FFR-CT outperformed other modalities
☢ Large portion of pts with angina have no evidence of obstructive #CAD on anatomical testing
☢ Traditional perfusion imaging does not identify pts with #CMD
☢ #CMD (#CFR<2.0) present in ~50% of pts with angina
☢ #CFR is more prognostic in♀than ♂
☢ CFR is a better prognostic factor than traditional img abnormalities
☢ #thinkPET is gold standard for eval of #CMD
☢ #whyCMR can be complementary to PET specially in #MINOCA
#CMD shares similar RFs w epicardial atherosclerosis (traditional ASCVD RFs) & is associated with several biomarkers of inflammation, oxidative stress & coagulation
In our IVUS study:
✅ Most patients with #CMD had significant plaque burden
✅ Patients with #CMD had higher plaque burden & more diffuse atherosclerosis as compared to patients w/o CMD
✅ Angina ➡ poor prognosis
✅ Angina with no obstructive CAD = ⬆ risks of CV events compared to no angina, even after adjusting for traditional RFs & co-morbidities
✅ What Is #CMD & Why Is It Important?
✅ Dx & Risk Stratification of #CMD: Stress Testing & Noninvasive Imaging
✅ Catheter-Based Techniques in Dx of #CMD
✅ Emerging Link Between #CMD & #HFpEF
✅ Phenotype-Based Mngmt of #CMD